Role of [18F]-FDG-PET/MDCT in evaluating early response in patients with Hodgkin's lymphoma.

about

PET-CT in oncological patients: analysis of informal care costs in cost-benefit assessment.Dynamic metabolic changes during the first 3 months after 90Y-ibritumomab tiuxetan radioimmunotherapy.

P2860

Q44764285-F396B983-4785-4F8D-8CB5-E0AB6737A0BF Q53059192-4B73A30E-90B2-4E95-AC45-F146D7985B5B

P2860

Role of [18F]-FDG-PET/MDCT in evaluating early response in patients with Hodgkin's lymphoma.

Item

http://www.wikidata.org/entity/Q45394964

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Role of [18F]-FDG-PET/MDCT in ...... ients with Hodgkin's lymphoma.

@en

Role of [18F]-FDG-PET/MDCT in ...... ients with Hodgkin's lymphoma.

@nl

type

Item

label

Role of [18F]-FDG-PET/MDCT in ...... ients with Hodgkin's lymphoma.

@en

Role of [18F]-FDG-PET/MDCT in ...... ients with Hodgkin's lymphoma.

@nl

prefLabel

Role of [18F]-FDG-PET/MDCT in ...... ients with Hodgkin's lymphoma.

@en

Role of [18F]-FDG-PET/MDCT in ...... ients with Hodgkin's lymphoma.

@nl

P1476

Role of [18F]-FDG-PET/MDCT in ...... tients with Hodgkin's lymphoma

@en

P2093

A Mancini

http://www.w3.org/2001/XMLSchema#string

C Ragano Caracciolo

http://www.w3.org/2001/XMLSchema#string

E Gaspari

http://www.w3.org/2001/XMLSchema#string

F Bolacchi

http://www.w3.org/2001/XMLSchema#string

F Della Gatta

http://www.w3.org/2001/XMLSchema#string

G Simonetti

http://www.w3.org/2001/XMLSchema#string

P2860

Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin for chemotherapy-naive patients with extensive-disease small cell lung cancer.

Primary hepatic (extranodal) lymphoma: utility of [(18)F]fluorodeoxyglucose-PET/CT.

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.

Overview of early response assessment in lymphoma with FDG-PET.

PET/CT for therapy response assessment in lymphoma.

Clinical utility of PET/CT in lymphoma.

Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches.

Effect of drug-induced cytotoxicity on glucose uptake in Hodgkin's lymphoma cells.

P2888

s11547-012-0792-8

P304

1250-1263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11547-012-0792-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

Roberta Danieli

Orazio Schillaci

A Orlacchio

P577

2012-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1020800426

http://www.w3.org/2001/XMLSchema#string

P698

22327919

http://www.w3.org/2001/XMLSchema#string

Role of [18F]-FDG-PET/MDCT in evaluating early response in patients with Hodgkin's lymphoma.

about

P2860

P2860

Role of [18F]-FDG-PET/MDCT in evaluating early response in patients with Hodgkin's lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698